PATIENT ALERT: Information regarding Coronavirus (COVID-19).  

Clinical Research & Trials

USO 17218

A Randomized, Double-Blind, Phase 3 Comparison Of Platinum-Based Therapy With TSR-042 And Niraparib Versus Standard Of Care Platinum-Based Therapy As First-Line Treatment Of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (3000-03-005/ENGOT-OV44)

 

Disease Types: GYN Cancer Research

Available at: